- Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience. Cristofanilli, M., Gonzalez-Angulo, A.M., Buzdar, A.U., Kau, S.W., Frye, D.K., Hortobagyi, G.N. Clin. Breast Cancer (2004)